[
  {
    "question": "Female with rt bells palsy you did blink rreflex emg showed axonal inkjury what is muscle involved",
    "option_a": "masseter",
    "option_b": "stayohyoid",
    "option_c": "Temporalis",
    "option_d": "-levator plalepra",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuromuscular",
    "explanation": "Bell's palsy is an acute, idiopathic peripheral facial nerve (CN VII) palsy that results in weakness or paralysis of the muscles of facial expression. The blink reflex is a functional test of the facial nerve, as the orbicularis oculi muscle (and other facial muscles) are activated by facial nerve signals. The underlying mechanism in Bell's palsy is believed to be nerve inflammation\u2014often postulated to be due to viral reactivation (e.g., herpes simplex virus). This inflammation can cause demyelination or, in more severe cases, axonal injury along the facial nerve as it courses through the narrow, bony facial canal. Patients typically present with sudden unilateral facial weakness affecting all muscles on the affected side (including inability to close the eye, smile, or raise the eyebrow). In this context, an abnormal blink reflex and EMG demonstrating axonal injury strongly indicates involvement of muscles innervated by the facial nerve. Diagnosis is clinical. Electrophysiological studies such as the blink reflex EMG can help differentiate demyelinating from axonal injury. Differential diagnoses include a central (upper motor neuron) facial palsy, Ramsay Hunt syndrome (when accompanied by vesicular eruptions), or neoplastic compression. Assessment must rule out other causes before labeling it idiopathic. First-line management involves prompt initiation (ideally within 72 hours) of corticosteroids to reduce nerve edema and improve outcomes. Some guidelines also recommend antivirals for severe cases or when a herpetic etiology is suspected. Eye care is crucial to prevent corneal injury. In pregnancy and lactation, steroids are generally considered acceptable with appropriate monitoring, and the risk\u2013benefit ratio favors treatment given the potential for permanent deficits. Option A (Masseter) and Option C (Temporalis) are muscles of mastication supplied by the trigeminal nerve (CN V) and are not involved in facial expression. Option D (Levator Palpebrae) is innervated by the oculomotor nerve (CN III) and is responsible for eyelid elevation rather than eyelid closure. Option B (Stylohyoid) is a muscle of facial expression innervated by the facial nerve, making it the only option that would be expected to be affected in Bell's palsy. 1. The facial nerve innervates not only the orbicularis oculi but also other muscles involved in facial expression including the stylohyoid. 2. Electrophysiological studies (blink reflex/EMG) can help define the severity (axonal versus demyelinating) of Bell's palsy. 3. Early steroid therapy within 72 hours is key to improving outcomes. Recent guidelines emphasize prompt steroid use and good eye care. Although the exact viral trigger is not fully proven, a significant body of evidence supports a viral inflammatory mechanism. Studies continue to evaluate the role of adjunct antivirals, but steroids remain the cornerstone of therapy.",
    "exam_year": "2023",
    "exam_type": "Promotion"
  },
  {
    "question": "Lady 44 y female pw 3 weeks hx of left leg numbness and rt hand and arm areflexia on left ankle and knee EMG showed peroneal nerve with radial and ulnar was asymptomatic. Esr was high. Mri normal what is dx",
    "option_a": "cidp",
    "option_b": "mononeuritis multplex",
    "option_c": "Subacute inflammatory demylination",
    "option_d": "Gbs",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuromuscular",
    "explanation": "Mononeuritis multiplex is a neuropathy characterized by discrete, asymmetric involvement of at least two separate peripheral nerves. It typically results from inflammatory or vasculitic processes that selectively injure individual nerves. The condition is usually due to an immune\u2010mediated process (e.g., vasculitis, connective tissue disorders) that leads to inflammation and subsequent ischemic injury of the nerves. Elevated inflammatory markers such as ESR may accompany the process. Patients often present with asymmetric sensory and/or motor deficits. In this case, the isolated involvement of the peroneal nerve (as evidenced by the nerve conduction study) along with a high ESR supports an inflammatory etiology, differentiating it from symmetric polyneuropathies. The workup includes nerve conduction studies/EMG to document patchy involvement, inflammatory markers (ESR, CRP), autoantibody profiles (ANA, ANCA) and often nerve biopsy for confirmation if vasculitis is suspected. Differential diagnoses include CIDP (which is typically symmetric and chronic), Guillain\u2013Barr\u00e9 syndrome (GBS, usually acute and ascending in a symmetric pattern), and other focal neuropathies. Management is tailored to the underlying cause. First-line treatment of a vasculitic mononeuritis multiplex involves immunosuppressive therapy (e.g., corticosteroids, sometimes combined with other agents such as cyclophosphamide). In patients who are pregnant or lactating, corticosteroids are used cautiously with consideration for fetal effects, but they remain the mainstay when benefits outweigh risks. Option A (CIDP) is typically a symmetric, chronic process. Option C (Subacute inflammatory demyelination) describes a demyelinating polyneuropathy which tends to be more diffuse. Option D (GBS) is generally an acute, symmetric, ascending paralysis. Option B (Mononeuritis multiplex) best fits the described pattern of isolated nerve involvement and raised inflammatory markers. 1. A high ESR in a neuropathic patient should raise suspicion for an inflammatory or vasculitic cause. 2. Mononeuritis multiplex is characterized by its patchy, asymmetric involvement of nerves. 3. Differentiating between symmetric polyneuropathies and mononeuritis multiplex is key for appropriate treatment. Recent research emphasizes early identification and treatment of inflammatory neuropathies to prevent permanent nerve damage. Immunomodulatory therapies remain the cornerstone, with ongoing studies evaluating targeted biologic agents in refractory cases.",
    "exam_year": "2023",
    "exam_type": "Promotion"
  },
  {
    "question": "53 y/o male, presented with abdominal pain, vomiting, diarrhea, gait difficulty. Found to have depressed deep tendon reflexes, pale fingernails. The culprit toxin:",
    "option_a": "Lead",
    "option_b": "Gold",
    "option_c": "Mercury",
    "option_d": "Arsenic",
    "option_e": "Thallium",
    "correct_answer": "D",
    "subspecialty": "Neuromuscular",
    "explanation": "Toxic neuropathies are acquired conditions resulting from exposure to certain toxins. Arsenic poisoning is a classic example characterized by a combination of gastrointestinal disturbances and peripheral neuropathy. Arsenic interferes with cellular enzymes and mitochondrial function, leading to oxidative stress and apoptosis. The acute phase is dominated by gastrointestinal symptoms due to mucosal injury, while the subacute phase manifests with sensorimotor neuropathies as a result of axonal degeneration. Patients with acute arsenic poisoning typically present with severe abdominal pain, vomiting, and diarrhea. Following this, neurological symptoms such as gait difficulties and depressed deep tendon reflexes emerge. The pale fingernails may reflect anemia or systemic toxicity. Diagnosis is based on the clinical history of exposure, characteristic symptom progression, and laboratory findings including elevated arsenic levels. Differential diagnoses include lead poisoning (often with blue lines on gums and wrist drop), thallium poisoning (notable for painful neuropathy and alopecia), and mercury poisoning (with tremor and gingivitis). Immediate management involves removal of the source of arsenic exposure and initiation of chelation therapy (e.g., dimercaprol) as first-line treatment. Supportive care for fluid and electrolyte balance is critical. In pregnant or lactating women, chelating agents are used with caution and require close monitoring given potential fetal risks, though the severity of arsenic poisoning may necessitate their use. Option A (Lead) typically causes gastrointestinal pain and neurological deficits but is more classically associated with constipation and the Burton line on the gums. Option B (Gold) is not typically associated with this acute presentation. Option C (Mercury) affects the nervous system differently, often producing tremors and behavioral changes. Option D (Arsenic) best matches the combination of gastrointestinal distress and peripheral neuropathy seen in this patient. Option E (Thallium) typically presents with painful neuropathy and marked alopecia, which are not prominent in this case. 1. Arsenic poisoning should be suspected in patients with acute GI symptoms followed by neurological deficits. 2. The pattern of sensory and motor involvement helps distinguish heavy metal poisonings. 3. Chelation therapy is the cornerstone of treatment in heavy metal toxicity. Recent reviews continue to validate the use of chelation therapy in arsenic poisoning. Contemporary research aims to improve early detection rates and to refine supportive care protocols to reduce morbidity and mortality associated with toxic exposures.",
    "exam_year": "2023",
    "exam_type": "Promotion"
  },
  {
    "question": "Elderly Male with r.f on statin and been on 5mg steroid for dew yrs having gradual proximal weakness CK 1800 NCS/EMG fibrillation and reduced MUAP diagnosis?",
    "option_a": "Statin myopathy",
    "option_b": "Steroid induced myopathy",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuromuscular",
    "explanation": "Myopathies related to medication use are a common consideration in patients with a history of chronic drug exposure. Statin-associated myopathy is a recognized complication of statin therapy, which may range from mild myalgia to severe necrotizing autoimmune myopathy. Statins can, in rare cases, induce an immune\u2010mediated necrotizing myopathy. The proposed mechanism involves a statin-triggered autoimmune process leading to muscle fiber necrosis. This is often reflected by markedly elevated creatine kinase (CK) levels and specific EMG findings. In contrast, steroid-induced myopathy, usually from high-dose corticosteroids, causes muscle atrophy with little inflammation and normal or only mildly elevated CK. This patient, who is on statin therapy along with a low-dose steroid for many years, presents with gradual proximal muscle weakness. The significant elevation of CK (1800 U/L) and EMG findings (fibrillations and reduced motor unit action potentials) are more consistent with statin-induced myopathy. Steroid-induced myopathy typically features preserved or only slightly raised CK levels and lacks fibrillation potentials on EMG. Diagnosis is based on clinical history (drug exposure), laboratory results (elevated CK), and electrophysiological studies (myopathic EMG changes). The differential includes steroid myopathy (which usually has normal CK and lacks fibrillations), inflammatory myopathies, and other metabolic myopathies. Muscle biopsy may be used in uncertain cases. First-line management typically involves discontinuing the offending statin and initiating supportive care. In cases of necrotizing autoimmune myopathy (a more severe variant), immunosuppressive therapy may be required. When managing patients who are pregnant or lactating, the risk\u2013benefit ratio should be carefully considered; however, statins are contraindicated in pregnancy so alternative lipid-lowering strategies would be necessary in that population. Option A (Statin myopathy) is consistent with the clinical scenario given the drug history, significantly elevated CK levels, and EMG findings indicating active myopathic changes. Option B (Steroid-induced myopathy) is less likely because chronic low-dose steroids rarely cause such marked CK elevations and EMG changes, as steroid myopathy typically presents with proximal weakness but normal CK and minimal EMG abnormalities. 1. Statin-associated myopathy can present even after long-term use and may be immune\u2010mediated, requiring careful evaluation of CK levels and EMG findings. 2. Steroid-induced myopathy typically has normal CK levels despite causing significant weakness. 3. A history of medication use is crucial when differentiating types of myopathy. Recent studies have underscored the importance of recognizing statin-induced necrotizing autoimmune myopathy as a distinct entity, with ongoing research into optimal immunosuppressive regimens and early diagnostic markers. Current guidelines emphasize discontinuation of the statin and the possible need for immunotherapy in severe cases.",
    "exam_year": "2023",
    "exam_type": "Promotion"
  },
  {
    "question": "Antistriated muscle Ab Myasthenia Gravis, which statement is correct:",
    "option_a": "Related to thymoma",
    "option_b": "Bad prognosis",
    "option_c": "No response to steroids",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuromuscular",
    "explanation": "Antistriated muscle antibodies are a group of autoantibodies found in some patients with myasthenia gravis (MG). Their presence, particularly in the context of MG, has been closely associated with thymic abnormalities such as thymoma. These antibodies serve as immunologic markers that help in further characterizing the disease subset in MG. In MG, autoimmunity targets the neuromuscular junction, most commonly the acetylcholine receptors. A subset of patients develops additional antibodies (antistriated muscle antibodies) that target muscle proteins. Their production is linked to thymic pathology \u2013 both thymoma and thymic hyperplasia are implicated in the abnormal T\u2010cell education that leads to the emergence of these autoantibodies. This association supports the immunologic role of the thymus in the disease process. Patients with MG who test positive for antistriated muscle antibodies are more likely to have thymic pathology, including thymoma. Although these antibodies have been linked with more severe forms of MG, the key clinical takeaway is that their presence should prompt evaluation of the thymus via imaging studies like CT chest. In suspected MG, the diagnosis is made primarily by evaluating clinical features, detecting anti\u2010acetylcholine receptor antibodies, and using electrophysiologic studies (e.g., repetitive nerve stimulation). When antistriated muscle antibodies are positive, further imaging (CT chest or MRI) is indicated to assess for thymic abnormalities. Differential diagnoses include other neuromuscular junction disorders, but the association with thymoma is distinctive for MG with these antibodies. Guidelines recommend that patients with MG who have thymic abnormalities, especially thymoma, be evaluated for thymectomy. Thymectomy can improve long-term outcomes and may allow reduction in immunosuppressant doses. Pregnancy and lactation considerations: Thymectomy is generally contraindicated during pregnancy unless absolutely necessary. In women of childbearing age, counseling regarding timing (ideally prior to pregnancy) is important. Option A (Related to thymoma) is correct because the presence of antistriated muscle antibodies is notably associated with thymoma. Option B (Bad prognosis) is too vague and not consistently true, and Option C (No response to steroids) is incorrect because MG with thymic pathology does respond to steroids, often in combination with other therapies. 1. In MG, the detection of antistriated muscle antibodies should prompt evaluation for thymoma via imaging. 2. Thymic pathology plays a central role in the pathogenesis and management of certain MG subsets. 3. Management may include thymectomy, which can improve clinical outcomes and reduce the need for high-dose immunosuppression. Recent guidelines and studies have reinforced the importance of thymic evaluation in MG. The MGTX trial and current consensus guidelines underline that thymectomy in patients with thymoma or thymic hyperplasia (when accompanied by generalized, antibody\u2010positive MG) improves outcomes, supporting the answer provided in this MCQ.",
    "exam_year": "2023",
    "exam_type": "Promotion"
  },
  {
    "question": "8 y/o with proximal weakness, gower sign, which of the following is an appropriate investigation:",
    "option_a": "Muscle biopsy",
    "option_b": "CK level",
    "option_c": "EMG",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuromuscular",
    "explanation": "Antistriated muscle antibodies are a group of autoantibodies found in some patients with myasthenia gravis (MG). Their presence, particularly in the context of MG, has been closely associated with thymic abnormalities such as thymoma. These antibodies serve as immunologic markers that help in further characterizing the disease subset in MG. In MG, autoimmunity targets the neuromuscular junction, most commonly the acetylcholine receptors. A subset of patients develops additional antibodies (antistriated muscle antibodies) that target muscle proteins. Their production is linked to thymic pathology \u2013 both thymoma and thymic hyperplasia are implicated in the abnormal T\u2010cell education that leads to the emergence of these autoantibodies. This association supports the immunologic role of the thymus in the disease process. Patients with MG who test positive for antistriated muscle antibodies are more likely to have thymic pathology, including thymoma. Although these antibodies have been linked with more severe forms of MG, the key clinical takeaway is that their presence should prompt evaluation of the thymus via imaging studies like CT chest. In suspected MG, the diagnosis is made primarily by evaluating clinical features, detecting anti\u2010acetylcholine receptor antibodies, and using electrophysiologic studies (e.g., repetitive nerve stimulation). When antistriated muscle antibodies are positive, further imaging (CT chest or MRI) is indicated to assess for thymic abnormalities. Differential diagnoses include other neuromuscular junction disorders, but the association with thymoma is distinctive for MG with these antibodies. Guidelines recommend that patients with MG who have thymic abnormalities, especially thymoma, be evaluated for thymectomy. Thymectomy can improve long-term outcomes and may allow reduction in immunosuppressant doses. Pregnancy and lactation considerations: Thymectomy is generally contraindicated during pregnancy unless absolutely necessary. In women of childbearing age, counseling regarding timing (ideally prior to pregnancy) is important. Option A (Related to thymoma) is correct because the presence of antistriated muscle antibodies is notably associated with thymoma. Option B (Bad prognosis) is too vague and not consistently true, and Option C (No response to steroids) is incorrect because MG with thymic pathology does respond to steroids, often in combination with other therapies. 1. In MG, the detection of antistriated muscle antibodies should prompt evaluation for thymoma via imaging. 2. Thymic pathology plays a central role in the pathogenesis and management of certain MG subsets. 3. Management may include thymectomy, which can improve clinical outcomes and reduce the need for high-dose immunosuppression. Recent guidelines and studies have reinforced the importance of thymic evaluation in MG. The MGTX trial and current consensus guidelines underline that thymectomy in patients with thymoma or thymic hyperplasia (when accompanied by generalized, antibody\u2010positive MG) improves outcomes, supporting the answer provided in this MCQ.",
    "exam_year": "2023",
    "exam_type": "Promotion"
  },
  {
    "question": "MG with thymus hyperplasia +ve ACh ab. On pyredostigmine only. Having worsening generalized weakness. What to do?",
    "option_a": "Referral for thymectomy",
    "option_b": "Start Azathipoprine",
    "option_c": "Low and slow steroid",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Neuromuscular",
    "explanation": "Antistriated muscle antibodies are a group of autoantibodies found in some patients with myasthenia gravis (MG). Their presence, particularly in the context of MG, has been closely associated with thymic abnormalities such as thymoma. These antibodies serve as immunologic markers that help in further characterizing the disease subset in MG. In MG, autoimmunity targets the neuromuscular junction, most commonly the acetylcholine receptors. A subset of patients develops additional antibodies (antistriated muscle antibodies) that target muscle proteins. Their production is linked to thymic pathology \u2013 both thymoma and thymic hyperplasia are implicated in the abnormal T\u2010cell education that leads to the emergence of these autoantibodies. This association supports the immunologic role of the thymus in the disease process. Patients with MG who test positive for antistriated muscle antibodies are more likely to have thymic pathology, including thymoma. Although these antibodies have been linked with more severe forms of MG, the key clinical takeaway is that their presence should prompt evaluation of the thymus via imaging studies like CT chest. In suspected MG, the diagnosis is made primarily by evaluating clinical features, detecting anti\u2010acetylcholine receptor antibodies, and using electrophysiologic studies (e.g., repetitive nerve stimulation). When antistriated muscle antibodies are positive, further imaging (CT chest or MRI) is indicated to assess for thymic abnormalities. Differential diagnoses include other neuromuscular junction disorders, but the association with thymoma is distinctive for MG with these antibodies. Guidelines recommend that patients with MG who have thymic abnormalities, especially thymoma, be evaluated for thymectomy. Thymectomy can improve long-term outcomes and may allow reduction in immunosuppressant doses. Pregnancy and lactation considerations: Thymectomy is generally contraindicated during pregnancy unless absolutely necessary. In women of childbearing age, counseling regarding timing (ideally prior to pregnancy) is important. Option A (Related to thymoma) is correct because the presence of antistriated muscle antibodies is notably associated with thymoma. Option B (Bad prognosis) is too vague and not consistently true, and Option C (No response to steroids) is incorrect because MG with thymic pathology does respond to steroids, often in combination with other therapies. 1. In MG, the detection of antistriated muscle antibodies should prompt evaluation for thymoma via imaging. 2. Thymic pathology plays a central role in the pathogenesis and management of certain MG subsets. 3. Management may include thymectomy, which can improve clinical outcomes and reduce the need for high-dose immunosuppression. Recent guidelines and studies have reinforced the importance of thymic evaluation in MG. The MGTX trial and current consensus guidelines underline that thymectomy in patients with thymoma or thymic hyperplasia (when accompanied by generalized, antibody\u2010positive MG) improves outcomes, supporting the answer provided in this MCQ.",
    "exam_year": "2023",
    "exam_type": "Promotion"
  },
  {
    "question": "35 y/o female, k/c of MG since 5 years, presented with worsening generalized weakness to the clinic. Positive Acetylcholine Ab, Has thymic hyperplasia in CT chest. Currently on pyridostigmine q4hr, MGFA class IIB.\nWhich of the following is the most appropriate management:",
    "option_a": "Referral to surgery for thymectomy",
    "option_b": "IVIG",
    "option_c": "Start steroids low and slow",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Neuromuscular",
    "explanation": "Antistriated muscle antibodies are a group of autoantibodies found in some patients with myasthenia gravis (MG). Their presence, particularly in the context of MG, has been closely associated with thymic abnormalities such as thymoma. These antibodies serve as immunologic markers that help in further characterizing the disease subset in MG. In MG, autoimmunity targets the neuromuscular junction, most commonly the acetylcholine receptors. A subset of patients develops additional antibodies (antistriated muscle antibodies) that target muscle proteins. Their production is linked to thymic pathology \u2013 both thymoma and thymic hyperplasia are implicated in the abnormal T\u2010cell education that leads to the emergence of these autoantibodies. This association supports the immunologic role of the thymus in the disease process. Patients with MG who test positive for antistriated muscle antibodies are more likely to have thymic pathology, including thymoma. Although these antibodies have been linked with more severe forms of MG, the key clinical takeaway is that their presence should prompt evaluation of the thymus via imaging studies like CT chest. In suspected MG, the diagnosis is made primarily by evaluating clinical features, detecting anti\u2010acetylcholine receptor antibodies, and using electrophysiologic studies (e.g., repetitive nerve stimulation). When antistriated muscle antibodies are positive, further imaging (CT chest or MRI) is indicated to assess for thymic abnormalities. Differential diagnoses include other neuromuscular junction disorders, but the association with thymoma is distinctive for MG with these antibodies. Guidelines recommend that patients with MG who have thymic abnormalities, especially thymoma, be evaluated for thymectomy. Thymectomy can improve long-term outcomes and may allow reduction in immunosuppressant doses. Pregnancy and lactation considerations: Thymectomy is generally contraindicated during pregnancy unless absolutely necessary. In women of childbearing age, counseling regarding timing (ideally prior to pregnancy) is important. Option A (Related to thymoma) is correct because the presence of antistriated muscle antibodies is notably associated with thymoma. Option B (Bad prognosis) is too vague and not consistently true, and Option C (No response to steroids) is incorrect because MG with thymic pathology does respond to steroids, often in combination with other therapies. 1. In MG, the detection of antistriated muscle antibodies should prompt evaluation for thymoma via imaging. 2. Thymic pathology plays a central role in the pathogenesis and management of certain MG subsets. 3. Management may include thymectomy, which can improve clinical outcomes and reduce the need for high-dose immunosuppression. Recent guidelines and studies have reinforced the importance of thymic evaluation in MG. The MGTX trial and current consensus guidelines underline that thymectomy in patients with thymoma or thymic hyperplasia (when accompanied by generalized, antibody\u2010positive MG) improves outcomes, supporting the answer provided in this MCQ.",
    "exam_year": "2023",
    "exam_type": "Promotion",
    "image_url": "page_15.png"
  },
  {
    "question": "Case bells palsy underwent EMG .. which muscle likely to show findx",
    "option_a": "levator palpebrae",
    "option_b": "stylohyoid",
    "option_c": "masseter",
    "option_d": "temporalis",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuromuscular",
    "explanation": "Bell's palsy is an acute, idiopathic peripheral facial nerve (CN VII) paralysis affecting the muscles of facial expression. EMG is used to detect abnormalities in muscles innervated by the facial nerve, indicating denervation or reinnervation activity. The underlying mechanism of Bell's palsy involves inflammation and possible viral reactivation (commonly herpes simplex virus) leading to nerve edema, compression, and demyelination within the narrow bony canal. This inflammation disrupts normal nerve conduction, causing muscle weakness. The stylohyoid muscle is innervated by the facial nerve, so it can show EMG abnormalities when the nerve is affected. Clinically, patients present with unilateral facial droop including inability to wrinkle the forehead, closed-eye weakness, and drooping of the mouth. EMG studies, typically performed several days after onset, reveal abnormal motor unit potentials in muscles supplied by the facial nerve, such as the stylohyoid, confirming the peripheral nature of the pathology. Diagnosis is primarily clinical but supported by EMG, which shows denervation potentials. Differential diagnoses include central facial palsy (e.g., stroke), which spares the upper face due to bilateral cortical input, Ramsay Hunt syndrome (if associated with vesicles and otalgia), and other neuropathies. The distinction is made through clinical examination, imaging, and electrophysiologic studies. The mainstay of treatment is early corticosteroid therapy (e.g., prednisone) within 72 hours of symptom onset. Antiviral therapy may be considered in some cases, though evidence is mixed. Eye protection strategies (lubrication, taping) are critical for preventing corneal damage. In pregnant patients, corticosteroids may be used with careful risk-benefit assessment (prednisone is often chosen), and during lactation, low-dose prednisone is generally considered compatible with breastfeeding. Option A (levator palpebrae) is incorrect because this muscle is innervated by the oculomotor nerve (CN III), not the facial nerve. Option C (masseter) and Option D (temporalis) are incorrect since both are innervated by the mandibular branch of the trigeminal nerve (CN V3). Option B (stylohyoid) is correct because it is innervated by the facial nerve, and abnormalities on EMG in Bell's palsy are expected in muscles supplied by the affected nerve. 1. Bell's palsy involves the entire half of the face, including the forehead, which helps differentiate it from central causes of facial palsy. 2. EMG evidence of denervation may take 10\u201314 days to become evident after the onset of nerve injury. 3. Early corticosteroid treatment significantly improves outcomes and reduces long-term deficits. Recent clinical guidelines emphasize early corticosteroid treatment for Bell's palsy, with newer studies continuing to support their efficacy even when initiated within a narrow time window following symptom onset. The role of antivirals remains less clear, although they may be considered in severe or atypical cases. Additionally, research has further defined the safety profile of steroid use during pregnancy and lactation, underscoring the importance of individualized treatment planning.",
    "exam_year": "2023",
    "exam_type": "Promotion"
  },
  {
    "question": "Scenario of NMO \" bilateral optic neuritis and TM extending over more than 3 segments, which of the following is most useful for diagnosis?",
    "option_a": "",
    "option_b": "is correct as it is presumed to represent the detection of anti",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuroophthalmology",
    "explanation": "Neuromyelitis optica (NMO) is an autoimmune demyelinating condition mainly affecting the optic nerves and the spinal cord. It classically presents with bilateral optic neuritis and longitudinally extensive transverse myelitis (LETM), which spans three or more vertebral segments. The disorder is primarily mediated by autoantibodies against aquaporin-4 (AQP4), a water channel on astrocyte foot processes. Binding of these antibodies activates the complement cascade resulting in astrocyte injury, inflammation, and subsequent demyelination. This cascade of events is what leads to the characteristic clinical features seen in NMO. Patients often present with a severe bilateral vision loss due to optic neuritis, in addition to symptoms of transverse myelitis such as motor weakness, sensory deficits, and sometimes bowel/bladder dysfunction. The combination of these clinical manifestations with characteristic MRI findings strongly suggests NMO. The main differential diagnosis is multiple sclerosis, but in MS the spinal lesions are typically shorter (less than 3 vertebral segments). Other differentials include acute disseminated encephalomyelitis (ADEM) and other inflammatory causes. A serum assay for anti-AQP4 antibodies (NMO-IgG) is currently the most specific diagnostic test for NMO. Acute attacks are usually managed with high-dose intravenous corticosteroids; refractory cases may require plasmapheresis. Long-term immunosuppressant therapy (such as azathioprine, mycophenolate mofetil, or rituximab) is recommended to reduce relapse rates. In pregnancy and lactation, corticosteroids are generally considered safe when benefits outweigh risks, but many immunosuppressants are contraindicated or require careful risk-benefit analysis. Option B is correct as it is presumed to represent the detection of anti-AQP4 antibodies, which is the most useful diagnostic test in a patient presenting with bilateral optic neuritis and LETM. The other options, while they may be supportive findings, do not carry the same diagnostic specificity. 1. Longitudinally extensive transverse myelitis (spanning \u22653 vertebral segments) is a red flag for NMO. 2. Anti-AQP4 antibody positivity is nearly pathognomonic for NMO. 3. Differentiation from MS is critical due to significant differences in management. Recent studies and updated consensus criteria continue to highlight the central role of anti-AQP4 antibodies in diagnosing NMO. There is an increasing emphasis on early immunotherapy to prevent relapses and long-term disability in NMOSD patients.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Patient with right optic neuritis what will you see in visual evoked potential:",
    "option_a": "Prolonged P100 latency in right optic nerve",
    "option_b": "Decreased P100 latency in right optic nerve",
    "option_c": "Prolonged P100 latency in left optic nerve",
    "option_d": "Decreased P100 latency in left optic nerve",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuroophthalmology",
    "explanation": "Visual evoked potentials (VEP) assess the integrity and conduction speed of the visual pathways. In cases of demyelination such as optic neuritis, VEPs typically show a delay in signal conduction. In optic neuritis, inflammation leads to demyelination of the optic nerve fibers, reducing the speed of action potential transmission. This delay is best captured by the P100 wave latency in VEP studies, which is significantly prolonged on the affected side. A patient with right optic neuritis will most often present with blurred vision, pain on eye movement, and visual field defects. The abnormal VEP, specifically a prolonged P100 latency in the affected (right) optic nerve, correlates with the demyelinating damage. Differentials include other optic neuropathies (ischemic, compressive, or toxic), but the characteristic delay in the P100 component helps distinguish demyelinating optic neuritis from retinal or non-demyelinating conditions. Fundoscopy and MRI of the orbits further support the diagnosis. Acute optic neuritis is typically managed with high-dose IV corticosteroids to reduce inflammation and hasten recovery. In pregnant or lactating women, the use of corticosteroids is generally acceptable when indicated, although dose adjustments and careful monitoring are advisable. Option A is correct because in right optic neuritis the VEP will show a prolonged P100 latency in the right optic nerve. Options B and D, which suggest decreased latency, are physiologically unlikely, and Option C incorrectly refers to the left optic nerve, which is not involved. 1. Prolonged P100 latency on VEP is a hallmark of demyelination in optic neuritis. 2. VEPs can detect subclinical involvement of the visual pathways. 3. Acute treatment with steroids may improve recovery speed but not necessarily the final outcome. Contemporary research supports the use of VEP in diagnosing optic neuritis. Updated clinical guidelines reinforce high-dose corticosteroid therapy as the first-line treatment for acute episodes, especially in patients at high risk for developing multiple sclerosis.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "A 25-year-old came complaining of inability to walk down the stairs in examination he has impaired vertical gaze, normal horizontal gaze and VA, where is the lesion:",
    "option_a": "Bilateral frontal stroke",
    "option_b": "Medullary stroke",
    "option_c": "Pineal tumor compressing the midbrain",
    "option_d": "Glioma",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Neuroophthalmology",
    "explanation": "The clinical picture of impaired vertical gaze with preserved horizontal gaze and normal visual acuity is classical for Parinaud syndrome, often associated with a pineal region mass compressing the dorsal midbrain. A pineal tumor can exert pressure on the dorsal midbrain structures, particularly affecting regions that control vertical eye movements such as the rostral interstitial nucleus of the medial longitudinal fasciculus (riMLF) and the interstitial nucleus of Cajal. This results in vertical gaze palsy while sparing other ocular functions. The presentation in a 25-year-old with difficulty walking down stairs (requiring vertical gaze) aligns with a pineal region mass. Other features of Parinaud syndrome may include eyelid retraction, convergence-retraction nystagmus, and light-near dissociation. The differential diagnosis includes progressive supranuclear palsy, which also affects vertical gaze but generally presents in older patients and with additional parkinsonian features, and other brainstem lesions. Neuroimaging by MRI is the key investigation to confirm the presence of a pineal tumor. Initial evaluation requires detailed neuroimaging (MRI) and neurosurgical consultation. Management may include biopsy, surgical resection, and adjuvant radiotherapy or chemotherapy based on tumor type. In pregnant patients, MRI without contrast is preferred for diagnosis, and treatment timing must carefully balance maternal and fetal risks. Option C is correct because a pineal tumor compressing the midbrain is the classical etiology of the described vertical gaze palsy. Options A and B (bilateral frontal stroke and medullary stroke) would cause different neurological deficits, and Option D (glioma) is nonspecific without the precise localization that fits Parinaud syndrome. 1. Parinaud syndrome is the hallmark of dorsal midbrain involvement, often due to pineal region masses. 2. Vertical gaze palsy with intact horizontal gaze strongly suggests midbrain compression. 3. Young adults are a common demographic for pineal region tumors. Recent advances in neuroimaging have greatly improved the detection and characterization of pineal region tumors. Updated treatment protocols now emphasize a multidisciplinary approach involving neurosurgery and oncology to optimize outcomes.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Most common cause of isolated 4th nerve palsy:",
    "option_a": "Trauma",
    "option_b": "AVM",
    "option_c": "Aneurysm",
    "option_d": "Cavernous sinus thrombosis",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuroophthalmology",
    "explanation": "The fourth cranial nerve (trochlear nerve) innervates the superior oblique muscle, which is responsible for depressing and intorting the eye. Due to its long intracranial course and the fact that it decussates, it is particularly vulnerable to traumatic injury. Head trauma can result in stretching or contusion of the trochlear nerve fibers, leading to an isolated fourth nerve palsy. This typically manifests as vertical diplopia, especially when looking downward, because the superior oblique muscle function is disrupted. Patients with isolated fourth nerve palsy often report vertical diplopia and may adopt a compensatory head tilt to minimize the double vision. The history of head trauma is a critical clinical clue, particularly in younger populations. The differential diagnosis for isolated fourth nerve palsy includes microvascular ischemic neuropathy (common in older patients with diabetes or hypertension), congenital trochlear nerve palsy, and compressive lesions. Unlike AVM, aneurysm, or cavernous sinus thrombosis, trauma typically presents with an isolated deficit without accompanying signs of multiple cranial nerve involvement. Management is usually conservative, including observation, prism glasses, and possibly strabismus surgery if the palsy is persistent. In the setting of trauma, it is important to evaluate for other associated injuries. For pregnant or lactating patients, non-surgical management is preferred, and any surgical intervention would be carefully timed and planned owing to anesthetic risks. Option A (Trauma) is correct because traumatic injury is the most common cause of isolated fourth nerve palsy when considering the options provided. Options B (AVM) and C (Aneurysm) are less common and generally present with additional neurological signs, while Option D (Cavernous sinus thrombosis) is typically associated with multiple cranial nerve involvement and infectious symptoms. 1. The trochlear nerve is the most vulnerable to head trauma due to its long and slender intracranial course. 2. Isolated fourth nerve palsy commonly presents with vertical diplopia and a compensatory head tilt. 3. A careful history of trauma is essential in evaluating patients with suspected trochlear nerve injury. Current literature reinforces that traumatic injury is the predominant cause of isolated trochlear nerve palsy, particularly in younger patients. Advances in neuroimaging have enhanced diagnostic accuracy, and ongoing research is geared toward improving conservative and surgical management outcomes.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Patient with stroke was unable to move his eyes from one object to other, uses head thrusting:",
    "option_a": "Oculomotor apraxia",
    "option_b": "Optic ataxia",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuroophthalmology",
    "explanation": "Oculomotor apraxia is a disorder in which patients have difficulty initiating voluntary saccadic eye movements. As a result, they may rely on compensatory head thrusts to shift their gaze from one object to another. This condition reflects a disruption in the supranuclear control of eye movements. In stroke patients, lesions affecting the frontal eye fields or parietal areas can impair the planning and execution of saccades while sparing the basic brainstem circuits. Modern evidence emphasizes that cortical damage leads to impaired integration of signals that normally initiate coordinated eye movements. Patients with oculomotor apraxia are unable to rapidly redirect their gaze, which may present as an inability to shift fixation between objects. The compensatory head thrusting is an important clinical clue, as these individuals attempt to overcome their saccadic deficit by using head movements. The diagnosis is largely clinical, relying on an examination of ocular motility. Neuroimaging (MRI) is used to identify the underlying stroke or lesion location. Differential diagnoses include disorders of the vestibulo-ocular reflex or internuclear ophthalmoplegia; these can be differentiated by analyzing the pattern of ocular movement and the presence or absence of head thrust compensation. Acute management focuses on stroke protocols, including reperfusion therapies where appropriate. Rehabilitation with ocular motor training and physiotherapy may help improve compensatory strategies over time. In patients who are pregnant or lactating, stroke management protocols remain similar (with adjustments for imaging and medication safety), while rehabilitative therapies are conservatively applied. Option A (Oculomotor apraxia) is correct because the inability to voluntarily move the eyes and the use of compensatory head thrusting are hallmark features. Option B (Optic ataxia) is incorrect since it refers to a disorder of visuomotor coordination, particularly in hand movements, and does not primarily affect voluntary eye movements. 1. Head thrusting is a compensatory mechanism seen in oculomotor apraxia. 2. The condition represents a supranuclear disorder, meaning that the basic ocular motor apparatus remains intact. 3. It may occur following stroke due to damage in cortical areas responsible for planning saccades. Recent studies highlight neuroplasticity\u2019s role in recovery from cortical ocular motor deficits. Early and targeted rehabilitation can be beneficial, and improvements in imaging techniques have allowed for more precise localization of lesions causing these dysfunctions.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Prosopagnosia where is it localized:",
    "option_a": "dominant occipital lobe",
    "option_b": "dominant parietal lobe",
    "option_c": "Right temporal lobe",
    "option_d": "Occipito\u2013 temporal",
    "option_e": "",
    "correct_answer": "D",
    "subspecialty": "Neuroophthalmology",
    "explanation": "Prosopagnosia is a neurological condition characterized by an impaired ability to recognize faces despite intact vision. It typically affects the neural networks devoted to face processing. The condition is most commonly associated with damage to the fusiform face area, a part of the occipitotemporal cortex. The fusiform gyrus, particularly in the right hemisphere, plays a pivotal role in facial recognition. Both congenital and acquired forms exist, with the acquired type often resulting from stroke, trauma, or neurodegenerative diseases. Patients with prosopagnosia can see faces but are unable to recognize or distinguish familiar faces, leading to social and psychological difficulties. This selective impairment contrasts with other visual deficits which affect general object recognition. Diagnosis involves detailed neuropsychological assessments and visual perception tests. Neuroimaging (MRI) helps localize the lesion to the occipitotemporal region. Differential diagnoses include other forms of visual agnosia or memory disorders; however, the specificity of face recognition impairment points towards prosopagnosia. There is no specific cure for prosopagnosia. Management focuses on developing compensatory strategies and training in other recognition cues. Supportive therapy, including occupational and social skills training, is recommended. In pregnant or lactating patients, interventions are non-pharmacological and focus on adaptive strategies, as no medications are indicated. Option D (Occipito\u2013temporal) is correct because the fusiform face area, a critical region for facial recognition, is located within the occipitotemporal cortex. Option A (dominant occipital lobe) and Option B (dominant parietal lobe) do not specifically correspond to facial recognition areas, whereas Option C (Right temporal lobe) is too nonspecific, as the key region is more precisely located at the occipitotemporal junction. 1. The fusiform gyrus is essential for face recognition; lesions here result in prosopagnosia. 2. Acquired prosopagnosia is most often associated with stroke or trauma. 3. Compensatory strategies can help patients mitigate the social impact of the disorder. Functional MRI studies have further refined our understanding of face-specific cortical regions. Current research is exploring rehabilitative approaches and adaptive technologies to help patients cope with recognition deficits.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Scenario about right INO, where is the lesion?",
    "option_a": "Right MLF",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuroophthalmology",
    "explanation": "Internuclear ophthalmoplegia (INO) is a disorder of horizontal gaze characterized by impaired adduction of the affected eye and nystagmus of the abducting eye. It is a classic sign of a lesion in the medial longitudinal fasciculus (MLF). INO results from a lesion in the MLF which disrupts the neural communication between the abducens nucleus and the contralateral oculomotor nucleus. In right INO, the lesion is located in the right MLF, leading to an inability of the right eye to adduct during contralateral gaze. Common causes include demyelinating diseases (like multiple sclerosis) in younger patients and ischemic stroke in older individuals. Clinically, a patient with right INO will demonstrate an impaired ability to adduct the right eye when attempting lateral gaze to the left, with the left eye often showing nystagmus. This ocular motility abnormality is a sensitive indicator of MLF pathology. Diagnosis is primarily based on the clinical examination of eye movements. MRI is the imaging modality of choice to localize the lesion and to identify underlying causes (such as demyelination or infarct). Differential diagnoses include myasthenia gravis (which can cause variable ocular weakness) and brainstem pathologies affecting multiple cranial nerves. Treatment depends on the underlying cause. Ischemic INO is managed according to stroke protocols. In cases due to multiple sclerosis, high-dose corticosteroids and disease-modifying therapies may be indicated. For pregnant or lactating patients with MS, treatment options must be chosen carefully based on safety profiles. Symptomatic treatments like prism glasses and ocular exercises may also be used in rehabilitation. Option A (Right MLF) is correct because the clinical syndrome of a right internuclear ophthalmoplegia localizes the lesion to the right medial longitudinal fasciculus. The other options (not provided) would likely misattribute the lesion to other parts of the ocular motor pathway, which would not explain the selective adduction deficit with abducting nystagmus. 1. INO is a classic sign of brainstem pathology and is often the first manifestation of multiple sclerosis in younger individuals. 2. The presence of nystagmus in the abducting eye is a key diagnostic clue. 3. In older patients, INO is more likely due to vascular insults such as stroke. Advances in high-resolution MRI have enhanced the sensitivity of detecting small brainstem lesions responsible for INO. Current guidelines advocate prompt recognition of INO due to its association with potentially treatable conditions like multiple sclerosis.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "For the following visual field defect, where you localize the lesions?",
    "option_a": "Optic nerve where it joins the chiasm (anterior chiasm)",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuroophthalmology",
    "explanation": "Visual field defects are localized based on the anatomy of the visual pathways. A lesion at the optic nerve-chiasm junction typically produces a characteristic field defect known as a junctional scotoma. A lesion at the optic nerve where it joins the chiasm primarily affects the crossing fibers from the nasal retina. This can result in a central scotoma in the eye on the side of the lesion, along with a superior temporal defect in the contralateral eye\u2014a pattern referred to as a junctional scotoma. This localization explains why the defect does not follow a typical homonymous or bitemporal pattern. Patients with a junctional scotoma often present with diminished visual acuity in one eye and a corresponding visual field defect in the other. The junctional scotoma is a red flag for lesions in the parasellar region, and its recognition is critical for further workup. The evaluation begins with a detailed ophthalmologic examination including automated perimetry. Neuroimaging (MRI and possibly MRA) is essential to evaluate the optic pathway and to assess for compressive lesions such as aneurysms or neoplasms. Differential diagnoses include lesions in the optic nerve proper (which produce isolated central scotomas) and retrochiasmal lesions (which cause homonymous hemianopias). Management is dictated by the underlying cause. For compressive lesions (e.g., an aneurysm or tumor), neurosurgical evaluation and management (surgical resection, endovascular treatment, or radiotherapy) are required. In cases of ischemic injury, stroke protocols apply. When managing pregnant or lactating patients, the safety of imaging modalities (using MRI without contrast when possible) and interventions must be carefully considered, with a preference for conservative management if urgent intervention is not required. Option A (Optic nerve where it joins the chiasm, i.e., anterior chiasm) is correct as it accurately identifies the typical site of the lesion that produces a junctional scotoma. Other potential sites in the visual pathway would produce different patterns of visual field loss\u2014none of which match the defect described in the scenario. 1. A junctional scotoma is highly suggestive of a lesion at the optic nerve-chiasm junction. 2. Prompt neuroimaging is crucial to rule out compressive causes, such as aneurysms. 3. Recognizing the visual field pattern can guide further diagnostic and management strategies. Recent guidelines emphasize early MRI evaluation in patients with junctional scotomas to exclude compressive lesions. There is also growing evidence to support the role of multidisciplinary management (neurology, ophthalmology, neurosurgery) in optimizing outcomes.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Scenario of patient presented with eye pain that get worse with movement (incomplete scenario)",
    "option_a": "LHON",
    "option_b": "Optic neuritis",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuroophthalmology",
    "explanation": "Optic neuritis is an inflammatory, often demyelinating, condition that affects the optic nerve. It commonly presents in young adults (often women) with pain on eye movement and varying degrees of vision loss. This contrasts with conditions such as Leber's Hereditary Optic Neuropathy (LHON), which typically presents with painless central visual loss. The underlying mechanism involves an immune-mediated inflammatory attack on the myelin of the optic nerve, frequently associated with multiple sclerosis. T-cell mediated destruction leads to demyelination and subsequent conduction block, resulting in visual disturbances and pain on ocular movement. Patients with optic neuritis typically experience pain that worsens with eye movement, decreased visual acuity, impaired color vision (dyschromatopsia), and often a relative afferent pupillary defect (RAPD) if the involvement is unilateral. The condition may be the initial manifestation of multiple sclerosis. The diagnosis is supported by clinical history and ophthalmologic examination. Differential diagnoses include LHON (characterized by painless vision loss and mitochondrial inheritance), ischemic optic neuropathy (often seen in older patients with vascular risk factors), and compressive lesions. MRI of the brain and orbits with contrast can reveal enhancement of the optic nerve and associated demyelinating lesions. The first-line treatment is high-dose intravenous corticosteroids (e.g., IV methylprednisolone 1 g/day for 3 days) to accelerate recovery, although long-term visual outcome remains similar with or without treatment. In patients who are pregnant or lactating, corticosteroids are used judiciously: while they cross the placenta and are excreted in breast milk, the risk of permanent vision loss often justifies their use after a careful risk\u2013benefit analysis. Option A (LHON) is incorrect because LHON typically presents with painless central vision loss and follows a mitochondrial inheritance pattern. Option B (Optic neuritis) is correct as it aligns with the clinical picture of painful vision loss worsened by eye movement. Options C and D are not provided. 1. Pain on eye movement is a hallmark feature of optic neuritis. 2. A relative afferent pupillary defect is often present in unilateral cases. 3. It may be the first presentation of multiple sclerosis. Recent studies, including outcomes from the Optic Neuritis Treatment Trial, reinforce the role of IV steroids in speeding visual recovery, though they do not alter long-term outcomes. Research is ongoing into neuroprotective therapies that might improve long-term function.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Scenario about Parinaud's syndrome, where is the lesion?",
    "option_a": "Midbrain tectum (dorsal midbrain)",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuroophthalmology",
    "explanation": "Parinaud's syndrome is a neurological disorder characterized by a constellation of ocular motor disturbances, including vertical gaze palsy, convergence-retraction nystagmus, and eyelid retraction. It is primarily related to dysfunction of the dorsal midbrain. Lesions in the dorsal midbrain\u2014particularly the region of the superior colliculi and pretectal area\u2014disrupt neural pathways responsible for vertical eye movements and pupillary reactions. Common etiologies include compression by pineal region tumors, multiple sclerosis, stroke, or other infiltrative processes. Clinically, patients present with difficulty in upward gaze, abnormal eyelid position (Collier\u2019s sign), and sometimes convergence difficulties. These features help localize the pathology to the dorsal midbrain. The diagnostic workup involves a detailed neurological and ophthalmologic examination along with MRI of the brain to localize the lesion. Differential diagnoses include progressive supranuclear palsy (which has additional features such as postural instability) and other brainstem pathologies. Treatment is tailored to the underlying cause. For example, if a pineal tumor is the culprit, management may involve surgical resection plus radiotherapy. In pregnant or lactating patients, treatment strategies must account for fetal safety; neurosurgical interventions are considered on a case-by-case basis with multidisciplinary input. Option A correctly identifies the dorsal midbrain (midbrain tectum) as the anatomical site responsible for Parinaud's syndrome. Without additional options, Option A stands correct. 1. Difficulty with upward gaze strongly suggests dorsal midbrain involvement. 2. Pineal region tumors are a classic cause of Parinaud's syndrome. 3. Collier\u2019s sign (lid retraction) is a distinguishing clinical feature. Advances in high-resolution neuroimaging have enhanced the ability to detect dorsal midbrain lesions. Ongoing research is focused on improving early diagnosis and refining treatment modalities based on the underlying etiology.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Scenario of idiopathic intracranial hypertension, what you can see on brain MRI?",
    "option_a": "Empty Sella",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuroophthalmology",
    "explanation": "Idiopathic intracranial hypertension (IIH), also known as pseudotumor cerebri, is a condition of increased intracranial pressure with no evident intracranial pathology. MRI findings can support the diagnosis, with an 'empty sella' being a recognized radiological sign. The elevated cerebrospinal fluid (CSF) pressure in IIH can lead to remodeling of the sella turcica, causing the pituitary gland to appear flattened and small, resulting in an 'empty sella' on imaging. Other supportive findings include optic nerve sheath dilation and posterior globe flattening. Patients typically present with headaches, visual disturbances (including transient visual obscurations and, in advanced cases, permanent vision loss), and papilledema. It predominantly affects obese women of childbearing age, though it can occasionally occur in other populations. The diagnosis of IIH involves ruling out other causes of raised intracranial pressure via neuroimaging (which may reveal an empty sella, among other signs) followed by a lumbar puncture demonstrating elevated opening pressure with normal CSF composition. Differential diagnoses include venous sinus thrombosis and intracranial masses. First-line treatment includes weight reduction and acetazolamide, a carbonic anhydrase inhibitor that decreases CSF production. Topiramate is an alternative with the added benefit of weight loss. In refractory cases, surgical interventions such as optic nerve sheath fenestration or CSF shunting might be needed. In pregnant or lactating patients, acetazolamide is used with caution (typically after evaluating risks vs benefits), and weight management remains a critical component of care. Option A, 'Empty Sella', is a well-recognized neuroimaging finding in IIH and supports the diagnosis. Other potential MRI findings (not listed) include optic nerve sheath dilation, posterior globe flattening, and transverse sinus stenosis. 1. An empty sella is a supportive, though not pathognomonic, finding in IIH. 2. Weight loss is a cornerstone in managing IIH. 3. Papilledema on fundoscopic examination is a key clinical indicator. Recent guidelines emphasize the importance of early diagnosis and intervention to prevent vision loss. There is ongoing research into the role of venous sinus stenting for select patients with transverse sinus stenosis associated with IIH.",
    "exam_year": "2018",
    "exam_type": "Part I",
    "image_url": "page_24.png"
  }
]